| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.445 | 6.047 | 11.144 | 18.902 | 19.010 | 19.117 | 23.901 |
| Total Income - EUR | - | - | - | 3.445 | 6.047 | 11.144 | 18.902 | 19.019 | 19.117 | 23.901 |
| Total Expenses - EUR | - | - | - | 65 | 140 | 6.026 | 395 | 6.399 | 15.563 | 7.398 |
| Gross Profit/Loss - EUR | - | - | - | 3.380 | 5.907 | 5.118 | 18.507 | 12.619 | 3.554 | 16.504 |
| Net Profit/Loss - EUR | - | - | - | 3.276 | 5.726 | 4.784 | 17.939 | 12.049 | 2.574 | 13.600 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Urolitopik S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 2.017 | 4.733 |
| Current Assets | - | - | - | 3.401 | 9.020 | 13.736 | 18.787 | 12.470 | 13.021 | 13.001 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 16.374 | 3.023 | 3.777 | 11.107 |
| Cash | - | - | - | 3.401 | 9.020 | 13.736 | 2.413 | 9.447 | 9.244 | 1.894 |
| Shareholders Funds | - | - | - | 3.319 | 8.981 | 13.595 | 17.980 | 12.090 | 14.638 | 13.641 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 82 | 40 | 141 | 807 | 380 | 400 | 4.093 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Urolitopik S.r.l.